MLLT10 and acute lymphoblastic leukemia: To our knowledge, this is the first description of the successful induction of durable remission in a completely drug resistant, pediatric PICALM::MLLT10 + BCP-ALL by venetoclax, which was identified by individual ex vivo DRP.